The present invention provides a compound of formula (I), (II), (III) and (IV) as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.
The present invention provides a compound of formula I, II, III and IV as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.
The present invention provides a compound of formula (I), (II), (III) and (IV) as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.
本发明提供了本文定义的式(I)、(II)、(III)和(IV)化合物及其药学上可接受的衍生物。本发明进一步提供了本发明化合物在治疗细菌感染和治疗 HIV 感染中的用途。还提供了包含本发明化合物的药物组合物。
A Proline-Based Phosphine Template for Staudinger Ligation
作者:Chung-Min Park、Wei Niu、Chunrong Liu、Tyler D. Biggs、Jiantao Guo、Ming Xian
DOI:10.1021/ol3022484
日期:2012.9.7
A proline-based phosphine template enabling a rapid Staudinger ligation of azide-containing substrates under mild conditions is reported. This reaction has a second-order rate constant of 1.12 M-1 s(-1). It is expected that the proline-based Staudinger ligation strategy will be a useful method for bioconjugation and proline based peptide coupling.